myla laigoldman  professional profile linkedin main content starts below myla laigoldmanceo at genecentric therapeutics inclocationraleighdurham north carolina areaindustrybiotechnologycurrentgenecentric therapeutics inc hatteras venture partners personalized science llcpreviousgenecentric diagnostics inc labcorpeducationcolumbia university college of physicians and surgeonsrecommendations person has recommended mylawebsitescompany website connectionsview myla’s full profile its freeyour colleagues classmates and  million other professionals are on linkedinview myla’s full profilesummarydr laigoldman is the chief executive officer and president of genecentric therapeutics inc she is also a founder and director of the company dr laigoldman spent more than  years at laboratory corporation of america holdings labcorp the last  years as executive vice president chief medical officer and chief scientific officer  she served on labcorp’s executive and management committees with strategic and operations responsibilities for  major genomic laboratories comprising more than  people during her tenure at the company she led all clinical scientific and medical activities including the introduction of more than  clinical assays her experience includes the development of partnerships licensing and acquisitions after leaving labcorp dr laigoldman became a venture partner at hatteras venture partners and is the managing partner of personalized science llc a consulting company founded to assist customers achieve successful adoption of innovative diagnostics dr laigoldman received her bs from the university of pensylvania and md from columbia university college of physicians and surgeons dr laigoldman is boardcertified in anatomic and clinical pathologyexperiencechief executive officergenecentric therapeutics incmay  – present  monthsventure partnerhatteras venture partnersaugust  – present  yearsmanaging partnerpersonalized science llcjanuary  – present  years  monthschief executive officergenecentric diagnostics incjune  – may   yearsexecutive vp cmo  csolabcorp –   yearsskillsdiagnosticshardware diagnosticsinfectious diseasesbiotechnologyoncologypersonalized medicinegenomicslifesciencescancercommercializationimmunologymolecular biologyclinical developmentdrug developmenttechnology transfersee drug discoverypharmaceutical industrybiopharmaceuticalshealthcaregeneticsbiochemistrymedical devicesclinical trialsmolecular diagnosticsproduct launchbioinformaticsfdardstrategylaboratoryventure capitalclinical researchmedicineregulatory affairsvaccinescrocorporate developmenttechnology evaluationlicensingstrategic alliancesscienceglobal marketinghematologyassay developmentventure financingmarket developmentmicrobiologycardiologyangel investingcell biologysee lesshows this translationgreat•has errorsthanks for your helpeducationcolumbia university college of physicians and surgeonsdoctor of medicine mddoctor of medicine md – university of pennsylvaniabachelor of arts ba biology concentration in ecologybachelor of arts ba biology concentration in ecology – recommendationsa preview of what linkedin members have to say about mylamyla is an incredible individual and is mutlitalented shes a true scientific leader and i have always enjoyed working with her look for great advancements from any organization that myla is associated withsee moresee lesssign up to see who recommended mylagroupspersonalized medicineboard of directors tglmolecular med triconglobal initiative against hpv  cervical cancer giahc and ncccbiomarker research and developmentview myla’s full profile tosee who you know in commonget introducedcontact myla directlyview myla’s full profilenot the myla you’re looking for view moreview this profile in another languageenglishgermanpeople also viewedmichelle albin dvmpublic health veterinariandavid deliacfo at nms labsamanda kizerbrett caponestudent at university of north carolina at chapel hillben millerchief operating officer at labcorp diagnosticsjoshua uronisclinical development scientist genecentric diagnosticscharity howellmarketing specialistjeff terrellhatteras venture partnersjune almenoff md phd facpbiopharma consultant board director former president  cmo furiexacquired by allergantara martinezdirector laboratory operations at epic sciencespublic profile badgeinclude this linkedin profile on other websitesview profile badgesfind a different myla laigoldmanfirst namelast nameexample myla laigoldmandr myla laigoldmanmanaging partnerunited statesmore professionals named myla laigoldmanlinkedin member directoryabcdefghijklmnopqrstuvwxyzmorebrowse members by country myla laigoldman  professional profile linkedin main content starts below myla laigoldmanceo at genecentric therapeutics inclocationraleighdurham north carolina areaindustrybiotechnologycurrentgenecentric therapeutics inc hatteras venture partners personalized science llcpreviousgenecentric diagnostics inc labcorpeducationcolumbia university college of physicians and surgeonsrecommendations person has recommended mylawebsitescompany website connectionsview myla’s full profile its freeyour colleagues classmates and  million other professionals are on linkedinview myla’s full profilesummarydr laigoldman is the chief executive officer and president of genecentric therapeutics inc she is also a founder and director of the company dr laigoldman spent more than  years at laboratory corporation of america holdings labcorp the last  years as executive vice president chief medical officer and chief scientific officer  she served on labcorp’s executive and management committees with strategic and operations responsibilities for  major genomic laboratories comprising more than  people during her tenure at the company she led all clinical scientific and medical activities including the introduction of more than  clinical assays her experience includes the development of partnerships licensing and acquisitions after leaving labcorp dr laigoldman became a venture partner at hatteras venture partners and is the managing partner of personalized science llc a consulting company founded to assist customers achieve successful adoption of innovative diagnostics dr laigoldman received her bs from the university of pensylvania and md from columbia university college of physicians and surgeons dr laigoldman is boardcertified in anatomic and clinical pathologyexperiencechief executive officergenecentric therapeutics incmay  – present  monthsventure partnerhatteras venture partnersaugust  – present  yearsmanaging partnerpersonalized science llcjanuary  – present  years  monthschief executive officergenecentric diagnostics incjune  – may   yearsexecutive vp cmo  csolabcorp –   yearsskillsdiagnosticshardware diagnosticsinfectious diseasesbiotechnologyoncologypersonalized medicinegenomicslifesciencescancercommercializationimmunologymolecular biologyclinical developmentdrug developmenttechnology transfersee drug discoverypharmaceutical industrybiopharmaceuticalshealthcaregeneticsbiochemistrymedical devicesclinical trialsmolecular diagnosticsproduct launchbioinformaticsfdardstrategylaboratoryventure capitalclinical researchmedicineregulatory affairsvaccinescrocorporate developmenttechnology evaluationlicensingstrategic alliancesscienceglobal marketinghematologyassay developmentventure financingmarket developmentmicrobiologycardiologyangel investingcell biologysee lesshows this translationgreat•has errorsthanks for your helpeducationcolumbia university college of physicians and surgeonsdoctor of medicine mddoctor of medicine md – university of pennsylvaniabachelor of arts ba biology concentration in ecologybachelor of arts ba biology concentration in ecology – recommendationsa preview of what linkedin members have to say about mylamyla is an incredible individual and is mutlitalented shes a true scientific leader and i have always enjoyed working with her look for great advancements from any organization that myla is associated withsee moresee lesssign up to see who recommended mylagroupspersonalized medicineboard of directors tglmolecular med triconglobal initiative against hpv  cervical cancer giahc and ncccbiomarker research and developmentview myla’s full profile tosee who you know in commonget introducedcontact myla directlyview myla’s full profilenot the myla you’re looking for view moreview this profile in another languageenglishgermanpeople also viewedmichelle albin dvmpublic health veterinariandavid deliacfo at nms labsamanda kizerbrett caponestudent at university of north carolina at chapel hillben millerchief operating officer at labcorp diagnosticsjoshua uronisclinical development scientist genecentric diagnosticscharity howellmarketing specialistjeff terrellhatteras venture partnersjune almenoff md phd facpbiopharma consultant board director former president  cmo furiexacquired by allergantara martinezdirector laboratory operations at epic sciencespublic profile badgeinclude this linkedin profile on other websitesview profile badgesfind a different myla laigoldmanfirst namelast nameexample myla laigoldmandr myla laigoldmanmanaging partnerunited statesmore professionals named myla laigoldmanlinkedin member directoryabcdefghijklmnopqrstuvwxyzmorebrowse members by country myla laigoldman  berufsprofil linkedin main content starts below teile dieses profils können maschinell übersetzt werden die übersetzung kann fehler enthalten übersetzung anzeigenoriginal anzeigenablehnenmyla laigoldmanceo at genecentric therapeutics incstandortraleighdurham und umgebung north carolinabranchebiotechnologieaktuellgenecentric therapeutics inc hatteras venture partners personalized science llcfrühergenecentric diagnostics inc labcorpausbildungcolumbia university college of physicians and surgeonsempfehlungen person hat myla laigoldman empfohlenwebseitenunternehmenswebseitekontaktesehen sie sich myla laigoldmans vollständiges profil an es ist kostenlosihre kollegen kommilitonen und  millionen weitere fach und führungskräfte sind bereits auf linkedinmyla laigoldmans vollständiges profil anzeigenzusammenfassungdr laigoldman is the chief executive officer and president of genecentric therapeutics inc she is also a founder and director of the company dr laigoldman spent more than  years at laboratory corporation of america holdings labcorp the last  years as executive vice president chief medical officer and chief scientific officer  she served on labcorp’s executive and management committees with strategic and operations responsibilities for  major genomic laboratories comprising more than  people during her tenure at the company she led all clinical scientific and medical activities including the introduction of more than  clinical assays her experience includes the development of partnerships licensing and acquisitions after leaving labcorp dr laigoldman became a venture partner at hatteras venture partners and is the managing partner of personalized science llc a consulting company founded to assist customers achieve successful adoption of innovative diagnostics dr laigoldman received her bs from the university of pensylvania and md from columbia university college of physicians and surgeons dr laigoldman is boardcertified in anatomic and clinical pathologyerfahrungchief executive officergenecentric therapeutics incmai  – heute  monateventure partnerhatteras venture partnersaugust  – heute  jahremanaging partnerpersonalized science llcjanuar  – heute  jahre  monatechief executive officergenecentric diagnostics incjuni  – mai   jahreexecutive vp cmo  csolabcorp –   jahredummydummyoriginal anzeigenübersetzung anzeigenkenntnissediagnostikdiagnosticshardwarediagnosehardware diagnosticsinfektionskrankheiteninfectious diseasesbiotechnologiebiotechnologyonkologieoncologypersonalisierte medizinpersonalized medicinegenomikgenomicslifescienceskrebscancervermarktungcommercializationimmunologieimmunologymolekularbiologiemolecular biologyklinische entwicklungclinical developmentarzneimittelentwicklungdrug developmenttechnologietransfertechnology transfer anzeigenpharmaforschungdrug discoverypharmaindustriepharmaceutical industrybiopharmazeutikabiopharmaceuticalsgesundheitspflegehealthcaregenetikgeneticsbiochemiebiochemistrymedizinproduktemedical devicesklinische studienclinical trialsmolekulardiagnostikmolecular diagnosticsprodukteinführungproduct launchbioinformatikbioinformaticslebensmittelüberwachungfdaforschung und entwicklungrdstrategisches managementstrategylabormedizinlaboratoryrisikokapitalventure capitalklinische forschungclinical researchmedizinmedicinearzneimittelzulassungregulatory affairsimpfstoffevaccinescrounternehmensentwicklungcorporate developmenttechnologiebewertungtechnology evaluationlizenzierunglicensingstrategische allianzenstrategic allianceswissenschaftscienceglobales marketingglobal marketinghämatologiehematologyassayentwicklungassay developmentrisikofinanzierungventure financingmarktentwicklungmarket developmentmikrobiologiemicrobiologykardiologiecardiologybusiness angelangel investingzellbiologiecell biologyweniger anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfeausbildungcolumbia universität college of physicians and surgeonscolumbia university college of physicians and surgeonsoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfedoctor of medicine mddoctor of medicine md – universität pennsylvaniauniversity of pennsylvaniaoriginal anzeigenübersetzung anzeigenwie finden sie diese übersetzunggut•fehlerhaftdanke für ihre hilfebachelor of arts ba biology concentration in ecologybachelor of arts ba biology concentration in ecology – empfehlungenhier ein kleiner vorgeschmack darauf was linkedin mitglieder über myla laigoldman sagenmyla is an incredible individual and is mutlitalented shes a true scientific leader and i have always enjoyed working with her look for great advancements from any organization that myla is associated withmehr anzeigenweniger anzeigenloggen sie sich ein um zu sehen wer myla laigoldman empfohlen hatgruppenpersonalized medicineboard of directors tglmolecular med triconglobal initiative against hpv  cervical cancer giahc and ncccbiomarker research and developmentsehen sie sich myla laigoldmans vollständiges profil an finden sie heraus welche gemeinsamen kontakte sie habenlassen sie sich vorstellenkontaktieren sie myla laigoldman direktmyla laigoldmans vollständiges profil anzeigendas ist nicht die person mit dem namen myla laigoldman die sie gesucht haben mehr anzeigenprofil in einer anderen sprache anzeigenenglischdeutschebenfalls angesehenmichelle albin dvmpublic health veterinariandavid deliacfo at nms labsamanda kizerbrett caponestudent at university of north carolina at chapel hillben millerchief operating officer at labcorp diagnosticsjoshua uronisclinical development scientist genecentric diagnosticscharity howellmarketing specialistjeff terrellhatteras venture partnersjune almenoff md phd facpbiopharma consultant board director former president  cmo furiexacquired by allergantara martinezdirector laboratory operations at epic sciencesbadge für ihr öffentliches profildieses linkedin profil auf anderen webseiten verwendenprofilbadges anzeigenweitere personen namens myla laigoldman suchenvornamenachnamebeispiel myla laigoldmandr myla laigoldmanmanaging partnervereinigte staatenweitere personen namens myla laigoldmanlinkedin mitgliederverzeichnisabcdefghijklmnopqrstuvwxyzmehrmitglieder nach land durchsuchenbeginn der umfrageschließenerweiternwas halten sie von dieser übersetzunghelfen sie dabei die maschinell übersetzten profile von linkedin zu verbessern ist ihnen einer dieser punkte aufgefallen falsches geschlechtunprofessioneller stilformatierungsfehlerfehlerhafte übersetzungwählen sie bitte mindestens eine antwort ausfeedback sendenende der umfragebeginn des dialogsschließendanke für ihre hilfewir verwenden diese informationen zur verbesserung unserer maschinellen übersetzungenende des dialogs sequenom welcomes myla laigoldman md to board of directors sequenom welcomes myla laigoldman md to board of directors sep    et from sequenom inc sequenom logo prnewsfotosequenom inc     facebook twitter pinterest sequenom logo prnewsfotosequenom inc san diego sept   prnewswire  sequenom inc nasdaq sqnm a life sciences company providing innovative diagnostic testing and genetic analysis solutions today announced the appointment of myla laigoldman md to its board of directors effective september   dr laigoldman has also been appointed to the science committee of the companys board of directors dr laigoldman is a managing partner at personalized science llc and chief executive officer of genecentric diagnostics inc and a venture partner with hatteras venture partners she previously served as executive vice president chief medical officer and chief scientific officer of laboratory corporation of america  she is a recognized author and speaker on clinical diagnostics including factors that lead to successful adoption of novel technologies we welcome dr laigoldman to our board and look forward to her contributions as a renowned voice in the pathology community to add strategic counsel to our shortterm and longterm growth efforts in the diagnostics market said harry f hixson jr phd chairman and ceo sequenom inc dr laigoldman received her undergraduate degree in biology from the university of pennsylvania and her medical degree from columbia university she completed a pathology residency and surgical pathology fellowship at ucla in los angeles and followed with a hematopathology fellowship at the university of north carolina at chapel hill as we continue to advance our role in driving forward the clinical applications of genetic technologies dr laigoldmans extensive experience in clinical laboratory medicine and specifically in molecular diagnostics will be extremely insightful and contribute meaningfully to the boards science committee said ronald m lindsay phd executive vice president research and development at sequenom about sequenom sequenom inc nasdaq sqnm is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions sequenom develops innovative technology products and diagnostic tests that target and serve discovery and clinical research and molecular diagnostics markets the company was founded in  and is headquartered in san diego california sequenom maintains a web site at httpwwwsequenomcom to which sequenom regularly posts copies of its press releases as well as additional information about sequenom interested persons can subscribe on the sequenom web site to email alerts or rss feeds that are sent automatically when sequenom issues press releases files its reports with the securities and exchange commission or posts certain other information to the web site forwardlooking statements except for the historical information contained herein the matters set forth in this press release including statements regarding the companys expectations regarding dr laigoldmans contributions to the company  the companys shortterm and longterm  growth efforts in the diagnostics market and the companys intentions and ability to continue to advance its role in driving forward the clinical applications of genetic technologies are forwardlooking statements within the meaning of the safe harbor provisions of the private securities litigation reform act of  these forwardlooking statements are subject to risks and uncertainties that may cause actual results to differ materially including the risks and uncertainties associated with market demand for and acceptance and use of the companys technology and tests such as the maternit plus test reliance upon the collaborative efforts of other parties the company or third parties obtaining or maintaining regulatory approvals that impact the companys business government regulation particularly with respect to diagnostic products and laboratory developed tests publication processes the performance of designed product enhancements the companys ability to develop and commercialize technologies and products particularly new technologies such as noninvasive prenatal diagnostics laboratory developed tests and genetic analysis platforms the companys financial position the companys ability to manage its existing cash resources or raise additional cash resources competition intellectual property protection and intellectual property rights of others litigation involving the company and other risks detailed from time to time in the companys filings with the securities and exchange commission including without limitation its quarterly report on form q for the quarter ended june   and its annual report on form k for the year ended december   these forwardlooking statements are based on current information that may change and you are cautioned not to place undue reliance on these forwardlooking statements which speak only as of the date of this press release all forwardlooking statements are qualified in their entirety by this cautionary statement and the company undertakes no obligation to revise or update any forwardlooking statement to reflect events or circumstances after the issuance of this press release logo httpphotosprnewswirecomprnhsqnmlogo source sequenom inc related links httpwwwsequenomcom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more sep    et preview sequenom announces participation at the morgan stanley global healthcare conference aug    et preview sequenom completes international distribution agreements to expand access to maternit plus prenatal testing service my news release contains wide tables view fullscreen looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search myla laigoldman ceo genecentric diagnostics timesjavascript is disabled market profiles login sign up login sign up   edit person myla laigoldman ceo at genecentric diagnostics location durham nc add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop myla laigoldman ceo at genecentric diagnostics location durham nc add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop dr myla laigoldman has over  years experience in the development commercialization and adoption of novel molecular diagnostic assays in  with drs chuck perou and neil hayes of the university of north carolina at chapel hill she cofounded genecentric diagnostics a hatteras fund iv company whose initial product the lung subtype platform lsptm enables oncologists make more informed treatment decisions for their lung cancer patients until her retirement on december   myla was executive vice president chief medical officer of laboratory corporation of america® holdings labcorp® where she managed labcorp’s national office of quality and science through which she was responsible for all quality science and medical activities for labcorp and its subsidiaries from  until april  myla also served as chief scientific officer of the company where she was responsible for r  d until  she managed the operations of the company’s center for molecular biology and pathology in research triangle park nc national genetics institute inc in los angeles ca and viromed laboratories inc in minneapolis mn additionally she held the position of medical director for the center for molecular biology and pathology from  to  myla joined the company in  myla earned an md from the college of physicians and surgeons at columbia university in new york and completed postgraduate training in internal medicine at st luke’s hospital in new york anatomic and clinical pathology at the ucla center for health sciences and hematopathology at the university of north carolina at chapel hill she is boardcertified in anatomic and clinical pathology community and board engagements myla serves on the executive committee of the board of directors for the medical foundation of north carolina myla also serves on the board of directors of sequenom  companies in career na related markets  colleagues na related investments alias na industry venture capital tags venture capital private equity topics of influence na na careers achievements investments related people edit view all myla laigoldmancareer  genecentric diagnostics ceo hatteras venture partners venture partner competencies edit view all myla laigoldmaneducation  university of pennsylvania columbia university edit myla laigoldmanachievements and recognitions add milestone no milestones has been recorded for myla laigoldman edit myla laigoldmanlinks add link no links has been recorded for myla laigoldman myla laigoldmaninvestmentsacquisitions no investments has been recorded for myla laigoldman myla laigoldmaninvestments representing others no investment reps has been recorded for myla laigoldman myla laigoldmanrelated people colleagues at genecentric diagnostics mark r miglarese cso view all myla laigoldmanrecommended market profiles  telemedicine  or more employees  companies social media marketing chiefmarteccom    employees  companies big data universe list of lists  or more employees  companies aggregated marketing technology  or more employees  companies shared economy landscape jeremiah owyang  or more employees  companies inside sales landscape  or more employees  companies myla p laigoldman phd md executive profile  biography  bloomberg july    pm et biotechnology company overview of genecentric therapeutics inc snapshotpeople  overviewboard memberscommittees executive profile myla p laigoldman phd mdchief executive officer president and director genecentric therapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr myla p laigoldman md phd is a venture partner of hatteras venture partners dr laigoldman cofounded and serves as the chief executive officer and president of genecentric diagnostics inc she served as scientific advisor of seventh sense biosystems inc she is managing partner at personalized science llc she served as the chief executive officer chief medical officer and chief scientific officer at cancerguide diagnostics inc she served as an executive  vice president at medical world communications inc she has deep experience in transitioning researchbased technologies into clinical medicine she served as the chief scientific officer executive vice president and medical director of laboratory corp of america holdings from april  to december   and also served as its chief medical officer until december   consultant from december   to april   and senior vice president since  where she was responsible for rd she served as a member of the scientific advisory board at tetralogic pharmaceuticals corporation tetralogic pharmaceuticals inc and served as its clinical advisor she managed the center for molecular biology and pathology at laboratory corp of america holdings’s research triangle park nc facility national genetics institute inc and viromed laboratories inc additionally she held the position of medical director for the center for molecular biology and pathology from  to  dr laigoldman joined rbl in  during her tenure at labcorp she managed labcorps national office of quality and science through which she was responsible for all quality science and medical activities for it and its subsidiaries she serves as a member of scientific advisory board at genvault corporation candiag inc and stemina biomarker discovery inc she has been a director of west pharmaceutical services inc since february  and qvella corporation she serves as a director of expression analysis inc and genecentric diagnostics inc she serves as a member of scientific advisory board at cypher genomics inc she served as a director of sequenom inc since september   until september   she has over  years experience in the development commercialization and adoption of novel molecular diagnostic assays she is board certified in anatomic and clinical pathology she received her medical degree md from the college of physicians and surgeons at columbia university in new york she completed a pathology residency and surgical pathology fellowship at ucla in los angeles she completed postgraduate training in internal medicine at st lukes hospital in new york anatomic and clinical pathology at the ucla center for health sciences and hematopathology at the university of north carolina at chapel hill dr laigoldman received her undergraduate degree in biology from the university of pennsylvaniaread full background corporate headquarters  tw alexander driveresearch triangle park north carolina united statesphone fax  board members memberships directorexpression analysis incchief executive officer president and directorgenecentric therapeutics incpresentdirectorwest pharmaceutical services inc education postdoctoral training university of north carolina at chapel hillmd columbia universitybachelors degree university of pennsylvania other affiliations laboratory corporation of america holdingsmedical world communications incsequenom incwest pharmaceutical services incuniversity of north carolina at chapel hillcolumbia universityuniversity of pennsylvaniaexpression analysis incgenvault corporationhatteras venture partnerstetralogic pharmaceuticals corporationstemina biomarker discovery incseventh sense biosystems inccancerguide diagnostics inconcotab inccypher genomics inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact genecentric therapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close wst myla p laigoldman insider trades for west pharmaceutical services inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close west pharmaceutical services inc nyse wst go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus west pharmaceutical services inc after hours  quotes are delayed by  min jul    pm wst quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual myla p laigoldman dr myla p laigoldman md is president chief executive officer  director at genecentric diagnostics inc chief executive  scientific officer at cancerguide diagnostics inc and venture partner at hatteras venture partners in  she founded and became the managing partner of personalized science llc a consulting company whose mission is to assist its customers achieve successful adoption of innovative diagnostics with actionable results for patients unmet medical needs in  with drs chuck perou and neil hayes of the university of north carolina at chapel hill she cofounded genecentric diagnostics focused on the development and commercialization of novel molecular diagnostic assays that enable oncologists and their patients make more informed individualized treatment decisions until her retirement on december   dr laigoldman md was executive vice president chief medical officer of laboratory corporation of america holdings labcorp where she managed labcorps national office of quality and science through which she was responsible for all quality science and medical activities for labcorp and its subsidiaries from  until april  she also served as chief scientific officer of the company where she was responsible for r  d dr laigoldman earned an md from the college of physicians and surgeons at columbia university in new york and completed postgraduate training in internal medicine at st lukes hospital in new york anatomic and clinical pathology at the ucla center for health sciences and hematopathology at the university of north carolina at chapel hill she is boardcertified in anatomic and clinical pathology transactions date shares transaction value     award at  per share      award at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr patrick j zenner nonexecutive chairman mr eric mark green president chief executive officer  director mr david a montecalvo svpglobal operations  supply chain mr william j federici chief financial officer  senior vice president mr eric resnick chief technology officer  vice president mr patrick a sim chief information officer  vice president mr donald a mcmillan vice presidententerprise business systems mr chris ryan vice president  general managerglobal generics mr mike schaefers vice presidentproduct management dr scott young vice presidentprimary container technology mr graham s reynolds vice president  general managerglobal biologics mr mike treadaway vp  general managercontract manufacturing ms karen a flynn chief commercial officer  senior vice president mr heino lennartz vice president  general managerglobal pharma mr paolo pucci director ms erin o’brien senior directormarketing mr daniel malone vice president  controller dr quintin john lai vice presidentcorporate development  strategy ms emily y denney headglobal communications ms annette f favorite chief human resources officer  senior vp mr george lloyd miller secretary senior vice president  general counsel ms deborah l keller independent director mr john h weiland independent director dr myla p laigoldman independent director dr william f feehery independent director mr douglas a michels independent director mr mark a buthman independent director dr paula a johnson independent director mr thomas w hofmann independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren awhy one analyst calls this the ‘chart of the week month and potentially year’ athe cracked benchmark why some investors want a new standard for bonds a moneymaking lessons from the richest man who ever lived age’s stock falls as jeff immelt’s th and last quarter is another disappointment anolan’s cinematic vision in ‘dunkirk’ is hollywood’s best defense against netflix aalphabet earnings a  billion hit for google potential youtube results for investors amicrosoft rides huge tax benefit from failing at smartphones to big earnings beat atrump says he has ‘complete power to pardon’ achipotle earnings media coverage of the latest illness scare will put earnings targets at risk aexxon earnings will stock trade higher on expected secondquarter beat apay tv expected to lose more than a million subscribers in latest quarter aqualcomm’s issues go beyond apple fight ayogaworks ipo pulled on valuation concerns not market conditions aamazon’s foray into groceries means more mergers of food companies experts say athis is what should really worry you about stocks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    access denied sorry access denied for our users’ safety profiles can’t be accessed via cloud computing systems if you believe you’re getting this message in error please contact us at supportdoximitycom need help return to doximitycom   access denied sorry access denied for our users’ safety profiles can’t be accessed via cloud computing systems if you believe you’re getting this message in error please contact us at supportdoximitycom need help return to doximitycom   access denied sorry access denied for our users’ safety profiles can’t be accessed via cloud computing systems if you believe you’re getting this message in error please contact us at supportdoximitycom need help return to doximitycom   access denied sorry access denied for our users’ safety profiles can’t be accessed via cloud computing systems if you believe you’re getting this message in error please contact us at supportdoximitycom need help return to doximitycom access denied access denied you dont have permission to access httphealthusnewscomdoctorsmylalaigoldman on this server reference fcea